Search results for "RADIOTHERAPY"

showing 10 items of 473 documents

Recurrence of a laryngeal spindle cell sarcoma with a transformation into a higher grade of malignancy.

2009

Primary malignant mesenchymal neoplasms of the larynx are rare. Sarcomas of the larynx account for <1% of all malignant laryngeal mesenchymal neoplasms. This report examines a case of a recurring laryngeal, initial benign-appearing mesenchymal tumour, which first changed its clinical phenotype without any histological signs of malignancy and later also its histological appearance with signs of malignancy. Finally, it even underwent a transformation into a higher grade of malignancy. In addition to this, the difficulties of allocating this tumour to the correct sarcoma subentity are shown.

LarynxMalePathologymedicine.medical_specialtybusiness.industryMesenchymal stem cellSarcomaGeneral Medicinemedicine.diseaseMalignancystomatognathic diseasesmedicine.anatomical_structureFatal OutcomeOtorhinolaryngologyMedicineHumansSurgeryRadiotherapy AdjuvantSpindle cell sarcomaSarcomaNeoplasm Recurrence LocalbusinessClinical phenotypeLaryngeal NeoplasmsAgedAuris, nasus, larynx
researchProduct

Soft palate preservation after tumor resection with transoral laser microsurgery

2012

Background: Management and preservation of the soft palate is dependent on clinical stage and tumor histology. However, available literature is scarce regarding the palate preservation with the use of laser CO 2 . Objectives : We report the results obtained after management with laser surgery and soft palate preservation in three patients with salivary gland neoplasms. Method: Three patients with minor salivary gland tumors were treated by means of transoral laser microsurgery. All tumors were assessed using magnetic resonance imaging. All tumors were >3 cm. Soft palate function was preserved and reconstruction was performed with primary closure. Patients began oral feeding the same day and…

Laser surgeryAdultmedicine.medical_specialtyMicrosurgerymedicine.medical_treatmentOdontologíamedicineHumansTransoral laser microsurgeryStage (cooking)General DentistryAgedSalivary glandSoft palatemedicine.diagnostic_testbusiness.industryMagnetic resonance imagingMicrosurgery:CIENCIAS MÉDICAS [UNESCO]Salivary Gland NeoplasmsCiencias de la saludSurgerymedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgeryResearch-ArticleFemaleLaser TherapyOral SurgeryPalate SoftbusinessOrgan Sparing TreatmentsChemoradiotherapyMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Safety and efficacy of intensity-modulated radiotherapy in the management of spermatic cord sarcoma.

2017

International audience; Purpose. - Spermatic cord sarcoma is a rare disease, which management remains controversial due to the lack of guidelines. The standard therapeutic approach is surgical: wide soft-tissue resection with radical inguinal orchidectomy, The diagnosis is made during the analysis of the specimen. The high rate of local recurrence indicates adjuvant radiotherapy of the tumor bed. The aim of this series is to determine the efficacy and safety of postoperative intensity-modulated radiotherapy for spermatic cord sarcomas. Patients and methods. - Our series included five consecutive cases of spermatic cord sarcoma treated between 2011 and 2014. The indications for radiotherapy …

LeiomyosarcomaMaleOrgans at Risk[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imagingmedicine.medical_treatment030232 urology & nephrologyParatesticular tumor[ SDV.CAN ] Life Sciences [q-bio]/Cancer[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine0302 clinical medicineMedicineOrchiectomy[ SDV.IB ] Life Sciences [q-bio]/BioengineeringPatternsFederationRapidarc[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/ImagingCancerAged 80 and overSpermatic CordSarcomaRadiotherapy DosageLiposarcomaMiddle AgedRetroperitoneal Sarcoma3. Good healthmedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisGenital Neoplasms MaleSoft-Tissue Sarcoma[SDV.IB]Life Sciences [q-bio]/BioengineeringSarcomaRadiodermatitisReoperationmedicine.medical_specialtyPrognostic-Factors[SDV.CAN]Life Sciences [q-bio]/Cancer[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineSpermatic cord03 medical and health sciencesTherapeutic approachHumansRadiology Nuclear Medicine and imagingIMRTAgedRetrospective StudiesRadiotherapybusiness.industryCancermedicine.diseaseRadiation-TherapySurgeryRadiation therapyRadiotherapy Intensity-ModulatedNeoplasm Recurrence LocalbusinessLigationOrchiectomyRare diseaseFollow-Up StudiesCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
researchProduct

A smart and operator independent system to delineate tumours in Positron Emission Tomography scans

2018

Abstract Positron Emission Tomography (PET) imaging has an enormous potential to improve radiation therapy treatment planning offering complementary functional information with respect to other anatomical imaging approaches. The aim of this study is to develop an operator independent, reliable, and clinically feasible system for biological tumour volume delineation from PET images. Under this design hypothesis, we combine several known approaches in an original way to deploy a system with a high level of automation. The proposed system automatically identifies the optimal region of interest around the tumour and performs a slice-by-slice marching local active contour segmentation. It automa…

Lung NeoplasmsComputer sciencemedicine.medical_treatmentPET imagingPattern Recognition Automated030218 nuclear medicine & medical imaging0302 clinical medicineNeoplasmsImage Processing Computer-AssistedSegmentationDiagnosis Computer-AssistedNeoplasm MetastasisRadiation treatment planningSettore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniObserver VariationActive contour modelmedicine.diagnostic_testBrain NeoplasmsPhantoms ImagingComputer Science ApplicationsHead and Neck NeoplasmsPositron emission tomography030220 oncology & carcinogenesis18F-fluoro-2-deoxy-d-glucoseAlgorithms18F-fluoro-2-deoxy-d-glucose and 11C-labeled methionine PET imagingSimilarity (geometry)Health InformaticsSensitivity and SpecificityNOActive contour algorithm03 medical and health sciencesFluorodeoxyglucose F18Predictive Value of TestsRegion of interestmedicineHumansFalse Positive ReactionsRetrospective Studies18F-fluoro-2-deoxy-d-glucose 11C-labeled methionine PET imaging Active contour algorithm Biological target volume Cancer segmentationbusiness.industryRadiotherapy Planning Computer-Assisted11C-labeled methionineReproducibility of ResultsPattern recognitionGold standard (test)Cancer segmentationRadiation therapyBiological target volumePositron-Emission TomographyArtificial intelligenceTomography X-Ray ComputedbusinessSoftwareComputers in Biology and Medicine
researchProduct

Dosimetric effect of respiratory motion on planned dose in whole-breast volumetric modulated arc therapy using moderate and ultra-hypofractionation.

2021

Abstract Background and purpose The interplay effect of respiratory motion on the planned dose in free-breathing right-sided whole-breast irradiation (WBI) were studied by simulating hypofractionated VMAT treatment courses. Materials and methods Ten patients with phase-triggered 4D-CT images were included in the study. VMAT plans targeting the right breast were created retrospectively with moderately hypofractionated (40.05 Gy in 15 fractions of 2.67 Gy) and ultra-hypofractionated (26 Gy 5 fractions of 5.2 Gy) schemes. 3D-CRT plans were generated as a reference. All plans were divided into respiratory phase-specific plans and calculated in the corresponding phase images. Fraction-specific d…

Lung Neoplasmsrespiratory motionrintasyöpäultrahypofractionationwhole-breast irradiationRadiotherapy Dosagevolumetric modulated arc therapysädehoitobreast cancersäteilyannoksetOncologyhengitysHumansRadiology Nuclear Medicine and imagingRadiation Dose HypofractionationRadiotherapy Intensity-ModulatedradiologiaRadiometryRetrospective StudiesRadiation oncology (London, England)
researchProduct

The impact of conventional and heavy ion irradiation on tumor cell migration in vitro.

2007

The influence of X-ray and (12)C heavy ion irradiation on tumor cell migration and of beta(3) and beta(1) integrin expression was investigated.Two different tumor cell lines (U87 glioma and HCT116 colon carcinoma cells) were irradiated with 1, 3, or 10 Gy X-rays or (12)C heavy ions. 24 h after irradiation a standardized Boyden Chamber assay for migration analysis was performed and cells were lysed for Western blotting.Radiation-induced influences were cell line- and radiation type-dependent. X-rays decreased HCT116 migration at higher doses and appear to increase U87 migration after 3 Gy. Heavy ions decreased migration of both cell lines dose-dependently. A trend of increased beta(3) and be…

LysisHeavy Ion RadiotherapyCell MovementGliomaCell Line TumorNeoplasmsmedicineTumor Cell MigrationHumansRadiology Nuclear Medicine and imagingIrradiationNeoplasm MetastasisneoplasmsRadiological and Ultrasound TechnologyChemistryIntegrin beta1RadiochemistryIntegrin beta3Dose-Response Relationship RadiationGliomaHeavy Ion Radiotherapymedicine.diseaseMolecular biologyIn vitroDose–response relationshipCell cultureColonic NeoplasmsInternational journal of radiation biology
researchProduct

Emerging MEK inhibitors

2010

IMPORTANCE OF THE FIELD: The Ras/Raf/MEK/ERK pathway is often activated by genetic alterations in upstream signaling molecules. Integral components of this pathway such as Ras and B-Raf are also activated by mutation. The Ras/Raf/MEK/ERK pathway has profound effects on proliferative, apoptotic and differentiation pathways. This pathway can often be effectively silenced by MEK inhibitors. AREAS COVERED BY THIS REVIEW: This review will discuss targeting of MEK which could lead to novel methods to control abnormal proliferation which arises in cancer and other proliferative diseases. This review will cover the scientific literature from 1980 to present and is a follow on from a review which fo…

MAPK/ERK pathwayCell signalingAntineoplastic Agentsmedicine.disease_causemekerkEnzyme activatorNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsmedicineAnimalsHumansPharmacology (medical)Protein phosphorylationProtein Kinase InhibitorsMEK inhibitorsCell ProliferationCancerPharmacologyapoptosis; cancer; erk; kinases; mek; mek inhibitors; proliferative disorders; protein phosphorylation; signal transductionproliferative disordersMutationKinasebusiness.industryapoptosisApoptosiCancerDrugs InvestigationalMAP Kinase Kinase Kinasesmedicine.diseaseprotein phosphorylationCell biologyEnzyme ActivationTreatment OutcomekinasesChemotherapy AdjuvantRadiotherapy AdjuvantSignal transductionbusinesssignal transductionExpert Opinion on Emerging Drugs
researchProduct

A top-down synthesis route to ultrasmall multifunctional Gd-based Silica nanoparticles for theranostic applications

2013

International audience; New, ultrasmall nanoparticles with sizes below 5 nm have been obtained. These small rigid platforms (SRP) are composed of a polysiloxane matrix with DOTAGA (1,4,7,10-tetraazacyclododecane-1-glutaric anhydride-4,7,10-triacetic acid)-Gd3+ chelates on their surface. They have been synthesised by an original top-down process: 1) formation of a gadolinium oxide Gd2O3 core, 2) encapsulation in a polysiloxane shell grafted with DOTAGA ligands, 3) dissolution of the gadolinium oxide core due to chelation of Gd3+ by DOTAGA ligands and 4) polysiloxane fragmentation. These nanoparticles have been fully characterised using photon correlation spectroscopy (PCS), transmission elec…

Magnetic Resonance SpectroscopySiloxanesGadoliniumtheranosticAnalytical chemistryContrast Mediachemistry.chemical_elementNanoparticle02 engineering and technologySubstance P010402 general chemistry01 natural sciencesCatalysisFluorescence spectroscopylaw.inventionHeterocyclic Compounds 1-RingMicroscopy Electron TransmissionDynamic light scatteringlawcancer[CHIM]Chemical SciencesChelationSpectroscopyElectron paramagnetic resonanceOrganic ChemistryGeneral ChemistryNuclear magnetic resonance spectroscopySilicon Dioxide021001 nanoscience & nanotechnologyMagnetic Resonance Imaging0104 chemical sciencesSpectrometry Fluorescencechemistrysilicananoparticlesgadolinium0210 nano-technologyRadiotherapy Image-GuidedNuclear chemistry
researchProduct

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treat…

2020

Background Cancer patients are thought to have an increased risk of developing severe Coronavirus Disease 2019 (COVID-19) infection and of dying from the disease. In this work, predictive factors for COVID-19 severity and mortality in cancer patients were investigated. Patients and Methods In this large nationwide retro-prospective cohort study, we collected data on patients with solid tumours and COVID-19 diagnosed between March 1 and June 11, 2020. The primary endpoint was all-cause mortality and COVID-19 severity, defined as admission to an intensive care unit (ICU) and/or mechanical ventilation and/or death, was one of the secondary endpoints. Results From April 4 to June 11, 2020, 1289…

Male0301 basic medicineCancer Researchmedicine.medical_treatmentDiseaselaw.inventionCohort Studies0302 clinical medicineMechanical ventilationRisk FactorslawNeoplasmsMedicineProspective StudiesProspective cohort studyOriginal ResearchCancerIntensive care unit3. Good healthDeathOncology030220 oncology & carcinogenesisFemaleFranceImmunotherapyCohort studymedicine.medical_specialtychemotherapy. radiotherapyAntineoplastic Agents[SDV.CAN]Life Sciences [q-bio]/Cancer03 medical and health sciencesInternal medicineHumansChemotherapyIntensive care unitMortalityPandemicsAgedRetrospective StudiesChemotherapyRadiotherapySARS-CoV-2business.industryCancerCOVID-19Retrospective cohort studyOdds ratiomedicine.diseaseAged; Antineoplastic Agents/adverse effects; Antineoplastic Agents/therapeutic use; COVID-19/mortality; Cohort Studies; Female; France/epidemiology; Humans; Male; Neoplasms/mortality; Neoplasms/therapy; Neoplasms/virology; Pandemics; Prospective Studies; Retrospective Studies; Risk Factors; SARS-CoV-2/isolation & purification; COVID-19; Cancer; Chemotherapy; Death; Immunotherapy; Intensive care unit; Mechanical ventilation; Mortality; Radiotherapy030104 developmental biologybusiness
researchProduct

KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma

2021

Despite curative-intent treatment, most patients with locally advanced esophageal cancer will experience disease recurrence or locoregional progression, highlighting the need for new therapies. Current guidelines recommend definitive chemoradiotherapy in patients ineligible for surgical resection, but survival outcomes are poor. Pembrolizumab is well tolerated and provides promising antitumor activity in patients with previously treated, advanced, unresectable esophageal/esophagogastric junction cancer. Combining pembrolizumab with chemoradiotherapy may further improve outcomes in the first-line setting. Here, we describe the design and rationale for the double-blind, Phase III, placebo-co…

Male0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyClinical Trial ProtocolEsophageal Neoplasmsesophageal adenocarcinomamedicine.medical_treatmentPembrolizumabAntibodies Monoclonal Humanizedchemotherapy03 medical and health sciences0302 clinical medicineClinical ProtocolsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaHumansesophageal cancerradiotherapyChemotherapybusiness.industryCancerChemoradiotherapyGeneral MedicineEsophageal cancermedicine.diseaseCombined Modality Therapyesophageal squamous cell carcinomaRadiation therapyClinical trial030104 developmental biologyOncologyResearch Design030220 oncology & carcinogenesisFemaleimmunotherapypembrolizumabbusinessChemoradiotherapyFuture Oncology
researchProduct